Literature DB >> 9701208

Spontaneous leak and transection of permanent subclavian catheters.

M Koller1, M Z Papa, A Zweig, G Ben-Ari.   

Abstract

BACKGROUND AND OBJECTIVES: Implanted central venous access ports are frequently used. Spontaneous break and catheter transection are serious but rare complications of permanent subclavian catheters. We report our experience with this serious complication and identify possible warning signs.
MATERIALS AND METHODS: Between 1990 and 1996, 285 permanent subclavian catheters were placed at the Sheba Medical Center, Tel Hashomer, Israel.
RESULTS: We evaluated the patient population for this complication and searched for possible warning signs. A total of 12 patients (4.2%) with this complication were identified, 8 with transection and distal embolization and 4 with a partial tear only. The pinch-off sign was noted as an early warning in only 5 patients. All other patients developed symptoms only immediately before the diagnosis of this complication. The mean duration from insertion to identification of tear or transection was 9.6 months (range 1-24 months).
CONCLUSION: Awareness and clinical suspicion are most important in identification and prevention of this serious complication. Catheters should be taken out when treatment is completed or after 12 months in order to prevent catheter breaks.

Entities:  

Mesh:

Year:  1998        PMID: 9701208     DOI: 10.1002/(sici)1096-9098(199807)68:3<166::aid-jso6>3.0.co;2-3

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Atypical pulmonary embolism of port catheter fragments in oncology patients.

Authors:  Alexey Surov; Karin Jordan; Michael Buerke; Monica Persing; Bettina Wollschlaeger; Curd Behrmann
Journal:  Support Care Cancer       Date:  2006-01-25       Impact factor: 3.603

2.  A retained pulmonary artery catheter fragment incidentally found lodged in the right heart 16 years after its insertion.

Authors:  Sarah El-Heis; Julian O M Ormerod; Badri Chandrasekaran; Steve Ramcharitar
Journal:  BMJ Case Rep       Date:  2013-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.